Details of the Drug

General Information of Drug (ID: DMUJ0EL)

Drug Name

BIIB132

Indication

Disease Entry	ICD 11	Status	REF
Spinocerebellar ataxia type 3	8A03.16	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antisense oligonucleotide

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ataxin-3 messenger RNA (ATXN3 mRNA)	TT6A17J	ATX3_HUMAN	Not Available	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05160558) A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3. U.S.National Institutes of Health.